JAGX
Jaguar Animal Health IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.00M
P/E Ratio
—
EPS
$-695.50
Beta
-0.10
52W High
$125.30
52W Low
$2.53
50-Day MA
$7.36
200-Day MA
$35.51
Dividend Yield
—
Profit Margin
-115.40%
Forward P/E
200.00
PEG Ratio
-0.02
About Jaguar Animal Health Inc
Jaguar Health, Inc., a commercial-stage pharmaceutical company, focuses on developing prescription drugs for people and animals with gastrointestinal upset, specifically chronic debilitating diarrhea. The company is headquartered in San Francisco, California.
Fundamentals
| Revenue (TTM) | $29.57M |
| Gross Profit (TTM) | $25.15M |
| EBITDA | $-23.60M |
| Operating Margin | 50.20% |
| Return on Equity | -411.60% |
| Return on Assets | -35.90% |
| Revenue/Share (TTM) | $154.72 |
| Book Value | $-38.12 |
| Price-to-Book | 1.62 |
| Price-to-Sales (TTM) | 0.07 |
| EV/Revenue | 1.304 |
| EV/EBITDA | -0.63 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 816.00% |
| Shares Outstanding | 722,020 |
| Float | 576,580 |
| % Insiders | 5.76% |
| % Institutions | 1.10% |
Historical Volatility
HV 10-Day
167.33%
HV 20-Day
136.90%
HV 30-Day
130.27%
HV 60-Day
142.31%
HV Rank
—
Volatility is currently expanding
More HEALTHCARE Stocks
Data last updated: 6/13/2026